248 related articles for article (PubMed ID: 25050558)
1. Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.
Park DJ; Tao K; Le Calvez-Kelm F; Nguyen-Dumont T; Robinot N; Hammet F; Odefrey F; Tsimiklis H; Teo ZL; Thingholm LB; Young EL; Voegele C; Lonie A; Pope BJ; Roane TC; Bell R; Hu H; Shankaracharya ; Huff CD; Ellis J; Li J; Makunin IV; John EM; Andrulis IL; Terry MB; Daly M; Buys SS; Snyder C; Lynch HT; Devilee P; Giles GG; Hopper JL; Feng BJ; Lesueur F; Tavtigian SV; Southey MC; Goldgar DE
Cancer Discov; 2014 Jul; 4(7):804-15. PubMed ID: 25050558
[TBL] [Abstract][Full Text] [Related]
2. Reevaluation of RINT1 as a breast cancer predisposition gene.
Li N; Thompson ER; Rowley SM; McInerny S; Devereux L; Goode D; ; Wong-Brown MW; Scott RJ; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res Treat; 2016 Sep; 159(2):385-92. PubMed ID: 27544226
[TBL] [Abstract][Full Text] [Related]
3. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
[TBL] [Abstract][Full Text] [Related]
4. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.
Win AK; Lindor NM; Young JP; Macrae FA; Young GP; Williamson E; Parry S; Goldblatt J; Lipton L; Winship I; Leggett B; Tucker KM; Giles GG; Buchanan DD; Clendenning M; Rosty C; Arnold J; Levine AJ; Haile RW; Gallinger S; Le Marchand L; Newcomb PA; Hopper JL; Jenkins MA
J Natl Cancer Inst; 2012 Sep; 104(18):1363-72. PubMed ID: 22933731
[TBL] [Abstract][Full Text] [Related]
5. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
[TBL] [Abstract][Full Text] [Related]
6. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study.
International Mismatch Repair Consortium
Lancet Oncol; 2021 Jul; 22(7):1014-1022. PubMed ID: 34111421
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.
Esteban-Jurado C; Vila-Casadesús M; Garre P; Lozano JJ; Pristoupilova A; Beltran S; Muñoz J; Ocaña T; Balaguer F; López-Cerón M; Cuatrecasas M; Franch-Expósito S; Piqué JM; Castells A; Carracedo A; Ruiz-Ponte C; Abulí A; Bessa X; Andreu M; Bujanda L; Caldés T; Castellví-Bel S
Genet Med; 2015 Feb; 17(2):131-42. PubMed ID: 25058500
[TBL] [Abstract][Full Text] [Related]
9. Association between the Lynch syndrome gene MSH2 and breast cancer susceptibility in a Canadian familial cancer registry.
Goldberg M; Bell K; Aronson M; Semotiuk K; Pond G; Gallinger S; Zbuk K
J Med Genet; 2017 Nov; 54(11):742-746. PubMed ID: 28779004
[TBL] [Abstract][Full Text] [Related]
10. Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study.
Harkness EF; Barrow E; Newton K; Green K; Clancy T; Lalloo F; Hill J; Evans DG
J Med Genet; 2015 Aug; 52(8):553-6. PubMed ID: 26101330
[TBL] [Abstract][Full Text] [Related]
11. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.
Walsh MD; Buchanan DD; Cummings MC; Pearson SA; Arnold ST; Clendenning M; Walters R; McKeone DM; Spurdle AB; Hopper JL; Jenkins MA; Phillips KD; Suthers GK; George J; Goldblatt J; Muir A; Tucker K; Pelzer E; Gattas MR; Woodall S; Parry S; Macrae FA; Haile RW; Baron JA; Potter JD; Le Marchand L; Bapat B; Thibodeau SN; Lindor NM; McGuckin MA; Young JP
Clin Cancer Res; 2010 Apr; 16(7):2214-24. PubMed ID: 20215533
[TBL] [Abstract][Full Text] [Related]
12. Mismatch repair gene mutation analysis and colonoscopy surveillance in Chinese Lynch syndrome families.
Fu L; Sheng JQ; Li XO; Jin P; Mu H; Han M; Huang JS; Sun ZQ; Li AQ; Wu ZT; Li SR
Cell Oncol (Dordr); 2013 Jun; 36(3):225-31. PubMed ID: 23640085
[TBL] [Abstract][Full Text] [Related]
13. Association of rare MSH6 variants with familial breast cancer.
Wasielewski M; Riaz M; Vermeulen J; van den Ouweland A; Labrijn-Marks I; Olmer R; van der Spaa L; Klijn JG; Meijers-Heijboer H; Dooijes D; Schutte M
Breast Cancer Res Treat; 2010 Sep; 123(2):315-20. PubMed ID: 19924528
[TBL] [Abstract][Full Text] [Related]
14. Commentary on "Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome." Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28].
See WA
Urol Oncol; 2013 Jul; 31(5):716. PubMed ID: 23796201
[TBL] [Abstract][Full Text] [Related]
15. BluepRINT for moderate-to-low penetrance cancer susceptibility genes needed: breast cancer and beyond.
Ngeow J; Eng C
Cancer Discov; 2014 Jul; 4(7):762-3. PubMed ID: 25002613
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
17. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
[TBL] [Abstract][Full Text] [Related]
18. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
Casey MJ; Bewtra C; Lynch HT; Snyder C; Stacy M; Watson P
Fam Cancer; 2013 Dec; 12(4):719-40. PubMed ID: 23666231
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
